# Application of UCAD for Diagnosing Urothelial Carcinoma.

> **NCT03998371** · — · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Urothelial Carcinoma
- Diagnoses Disease
- Chromosomal Abnormality
- Urine Marking

## Interventions

- **DIAGNOSTIC_TEST:** Low-coverage whole-genome sequencing of urine exfoliated cells

## Key facts

- **NCT ID:** NCT03998371
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-05
- **Primary completion:** 2020-05-05
- **Final completion:** 2020-05-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998371, "Application of UCAD for Diagnosing Urothelial Carcinoma.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03998371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*